Terms: = Thyroid cancer AND FOXO1, Q12778, FOXO1A, 2308, ENSG00000150907, FKH1, FKHR AND Prognosis
3 results:
1. KCTD12 promotes G1/S transition of breast cancer cell through activating the AKT/foxo1 signaling.
Ye RY; Kuang XY; Zeng HJ; Shao N; Lin Y; Wang SM
J Clin Lab Anal; 2020 Aug; 34(8):e23315. PubMed ID: 32207860
[TBL] [Abstract] [Full Text] [Related]
2. Long non-coding RNA ASMTL-AS1 inhibits tumor growth and glycolysis by regulating the miR-93-3p/miR-660/foxo1 axis in papillary thyroid carcinoma.
Feng Z; Chen R; Huang N; Luo C
Life Sci; 2020 Mar; 244():117298. PubMed ID: 31953163
[TBL] [Abstract] [Full Text] [Related]
3. Chemotherapy resistance and metastasis-promoting effects of thyroid hormone in hepatocarcinoma cells are mediated by suppression of foxo1 and Bim pathway.
Chi HC; Chen SL; Cheng YH; Lin TK; Tsai CY; Tsai MM; Lin YH; Huang YH; Lin KH
Cell Death Dis; 2016 Aug; 7(8):e2324. PubMed ID: 27490929
[TBL] [Abstract] [Full Text] [Related]
